- OUTLOOK
Taking the tripping out of psychedelic medicine
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 609, S80-S82 (2022)
doi: https://doi.org/10.1038/d41586-022-02869-4
This article is part of Nature Outlook: Psychedelic medicine, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Ly, C. et al. Cell Rep. 23, 3170–3182 (2018).
Dunlap, L. E. et al. J. Med. Chem. 63, 1142–1155 (2020).
Cameron, L. P. et al. Nature 589, 474–479 (2021).
Kaplan, A. L. et al. Nature https://doi.org/10.1038/s41586-022-05258-z (2022).
Cao, D. et al. Science 375, 403–411 (2022).
Dong, C. et al. Cell 184, 2779–2792 (2021).
Davoudian, P. A., Shao, L.-X. & Kwan, A. C. Preprint at bioRxiv https://doi.org/10.1101/2022.03.18.484437 (2022).
de la Fuente Revenga, M. et al. Cell Rep. 37, 109836 (2021).